vs
Side-by-side financial comparison of 4D Molecular Therapeutics, Inc. (FDMT) and Kennedy-Wilson Holdings, Inc. (KW). Click either name above to swap in a different company.
Kennedy-Wilson Holdings, Inc. is the larger business by last-quarter revenue ($120.6M vs $85.1M, roughly 1.4× 4D Molecular Therapeutics, Inc.). Kennedy-Wilson Holdings, Inc. runs the higher net margin — 48.1% vs 22.8%, a 25.3% gap on every dollar of revenue. On growth, 4D Molecular Therapeutics, Inc. posted the faster year-over-year revenue change (8508900.0% vs -11.0%). 4D Molecular Therapeutics, Inc. produced more free cash flow last quarter ($28.5M vs $-55.2M). Over the past eight quarters, 4D Molecular Therapeutics, Inc.'s revenue compounded faster (5412.6% CAGR vs -6.0%).
4D Molecular Therapeutics is a clinical-stage biotechnology company specializing in the research and development of targeted adeno-associated virus (AAV) gene therapies. Its core product candidates address unmet medical needs in ophthalmology, cardiology, and pulmonary disease segments, serving global patient populations with rare and common hard-to-treat conditions.
Kennedy Wilson is a real estate investment company headquartered in Beverly Hills, California, United States.
FDMT vs KW — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $85.1M | $120.6M |
| Net Profit | $19.4M | $58.0M |
| Gross Margin | — | — |
| Operating Margin | 17.3% | 57.3% |
| Net Margin | 22.8% | 48.1% |
| Revenue YoY | 8508900.0% | -11.0% |
| Net Profit YoY | 139.1% | 32.7% |
| EPS (diluted) | $0.43 | $0.22 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $85.1M | $120.6M | ||
| Q3 25 | $90.0K | $116.4M | ||
| Q2 25 | $15.0K | $135.7M | ||
| Q1 25 | $14.0K | $128.3M | ||
| Q4 24 | $1.0K | $135.5M | ||
| Q3 24 | $3.0K | $127.5M | ||
| Q2 24 | $5.0K | $132.0M | ||
| Q1 24 | $28.0K | $136.4M |
| Q4 25 | $19.4M | $58.0M | ||
| Q3 25 | $-56.9M | $-10.2M | ||
| Q2 25 | $-54.7M | $5.6M | ||
| Q1 25 | $-48.0M | $-29.6M | ||
| Q4 24 | — | $43.7M | ||
| Q3 24 | $-43.8M | $-66.8M | ||
| Q2 24 | $-35.0M | $-48.3M | ||
| Q1 24 | $-32.4M | $37.7M |
| Q4 25 | 17.3% | 57.3% | ||
| Q3 25 | -67983.3% | -6.2% | ||
| Q2 25 | -396373.3% | 7.4% | ||
| Q1 25 | -383007.1% | -26.9% | ||
| Q4 24 | — | 36.7% | ||
| Q3 24 | -1704400.0% | -60.8% | ||
| Q2 24 | -849120.0% | -45.5% | ||
| Q1 24 | -136200.0% | 47.2% |
| Q4 25 | 22.8% | 48.1% | ||
| Q3 25 | -63195.6% | -8.8% | ||
| Q2 25 | -364386.7% | 4.1% | ||
| Q1 25 | -342657.1% | -23.1% | ||
| Q4 24 | — | 32.3% | ||
| Q3 24 | -1461433.3% | -52.4% | ||
| Q2 24 | -699060.0% | -36.6% | ||
| Q1 24 | -115717.9% | 27.6% |
| Q4 25 | $0.43 | $0.22 | ||
| Q3 25 | $-1.01 | $-0.15 | ||
| Q2 25 | $-0.98 | $-0.05 | ||
| Q1 25 | $-0.86 | $-0.30 | ||
| Q4 24 | — | $0.24 | ||
| Q3 24 | $-0.79 | $-0.56 | ||
| Q2 24 | $-0.63 | $-0.43 | ||
| Q1 24 | $-0.66 | $0.19 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $402.7M | $184.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $505.7M | $1.5B |
| Total Assets | $566.7M | $6.6B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $402.7M | $184.5M | ||
| Q3 25 | $305.1M | $382.6M | ||
| Q2 25 | $293.2M | $309.1M | ||
| Q1 25 | $321.4M | $356.6M | ||
| Q4 24 | $424.9M | $217.5M | ||
| Q3 24 | $501.9M | $367.1M | ||
| Q2 24 | $541.9M | $366.5M | ||
| Q1 24 | $525.9M | $541.9M |
| Q4 25 | $505.7M | $1.5B | ||
| Q3 25 | $369.0M | $1.5B | ||
| Q2 25 | $420.9M | $1.6B | ||
| Q1 25 | $469.7M | $1.6B | ||
| Q4 24 | $510.6M | $1.6B | ||
| Q3 24 | $552.9M | $1.6B | ||
| Q2 24 | $588.3M | $1.7B | ||
| Q1 24 | $600.6M | $1.7B |
| Q4 25 | $566.7M | $6.6B | ||
| Q3 25 | $424.0M | $6.7B | ||
| Q2 25 | $473.6M | $6.8B | ||
| Q1 25 | $515.7M | $7.2B | ||
| Q4 24 | $560.4M | $7.0B | ||
| Q3 24 | $604.0M | $7.4B | ||
| Q2 24 | $620.1M | $7.5B | ||
| Q1 24 | $629.9M | $7.7B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $28.6M | $11.4M |
| Free Cash FlowOCF − Capex | $28.5M | $-55.2M |
| FCF MarginFCF / Revenue | 33.5% | -45.8% |
| Capex IntensityCapex / Revenue | 0.1% | 55.2% |
| Cash ConversionOCF / Net Profit | 1.47× | 0.20× |
| TTM Free Cash FlowTrailing 4 quarters | $-109.9M | $-103.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $28.6M | $11.4M | ||
| Q3 25 | $-46.5M | $-7.6M | ||
| Q2 25 | $-43.4M | $42.0M | ||
| Q1 25 | $-47.8M | $-51.9M | ||
| Q4 24 | $-134.6M | $55.1M | ||
| Q3 24 | $-29.4M | $-5.6M | ||
| Q2 24 | $-30.2M | $36.7M | ||
| Q1 24 | $-29.1M | $-5.6M |
| Q4 25 | $28.5M | $-55.2M | ||
| Q3 25 | $-46.6M | $-18.0M | ||
| Q2 25 | $-43.4M | $29.4M | ||
| Q1 25 | $-48.4M | $-59.7M | ||
| Q4 24 | $-138.4M | $-76.5M | ||
| Q3 24 | $-31.2M | $-27.7M | ||
| Q2 24 | $-30.6M | $-500.0K | ||
| Q1 24 | $-29.8M | $-57.1M |
| Q4 25 | 33.5% | -45.8% | ||
| Q3 25 | -51765.6% | -15.5% | ||
| Q2 25 | -289620.0% | 21.7% | ||
| Q1 25 | -345635.7% | -46.5% | ||
| Q4 24 | -13837100.0% | -56.5% | ||
| Q3 24 | -1038966.7% | -21.7% | ||
| Q2 24 | -611840.0% | -0.4% | ||
| Q1 24 | -106421.4% | -41.9% |
| Q4 25 | 0.1% | 55.2% | ||
| Q3 25 | 101.1% | 8.9% | ||
| Q2 25 | 440.0% | 9.3% | ||
| Q1 25 | 4507.1% | 6.1% | ||
| Q4 24 | 378600.0% | 97.1% | ||
| Q3 24 | 59266.7% | 17.3% | ||
| Q2 24 | 6980.0% | 28.2% | ||
| Q1 24 | 2535.7% | 37.8% |
| Q4 25 | 1.47× | 0.20× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 7.50× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 1.26× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | -0.15× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FDMT
Segment breakdown not available.
KW
| Consolidated Portfolio Segment | $84.9M | 70% |
| Investment Management Fees | $30.4M | 25% |
| Real Estate | $5.1M | 4% |
